2 min read

UBC’s COVID-19 Response

UBC is dedicated to providing continuity of service for our clients and patients during this time.
UBC is dedicated to providing continuity of service for our clients and patients during this time.

United BioSource LLC (UBC) is closely monitoring developments related to the COVID-19 pandemic to ensure the safety of our employees, patients, and the communities we serve. We are continuing to follow closely daily updates and guidance from the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and other national and global health organizations.

We are also taking concrete steps to meet our commitments to clients and business partners by regularly updating our business continuity plans. We can assure you that UBC remains committed to business continuity while protecting patients, employees, and our clients.

We recognize that the situation is evolving and have already taken several steps to mitigate risk, including:

•       Providing flexible work arrangements where appropriate

•       Evolving our business continuity plans to ensure flexible and dependable continued service and product delivery

•       Restricting non-essential visitors to our office locations

•       Restricting business travel based on updated governmental travel advice

We are continuously assessing the impact of COVID-19 on our client programs, including contingency planning relative to expected timelines and deliverables. UBC prioritizes the health and well-being of our employees and their families, the patients and customers we serve, and the communities in which we live and work.

Please reach out if you have any questions or concerns. We stand ready to assist you however we can.

Other Recent Posts

Press
5 min read

UBC Announces Partnership with Osmind to Advance the Future of Mental Health Treatment and Research within REMS

First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes
Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.
Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.